Successful treatment of subacute cutaneous lupus erythematosus with mycophenolate mofetil.
about
Current and emerging treatment options in the management of lupusUpdate on the management of cutaneous lupus erythematosus.Mycophenolate mofetil for non-renal manifestations of systemic lupus erythematosus: a systematic review.A randomized, blinded, parallel-group, pilot trial of mycophenolate mofetil (CellCept) compared with interferon beta-1a (Avonex) in patients with relapsing-remitting multiple sclerosis.A one-year prospective, randomized, placebo-controlled, quadruple-blinded, phase II safety pilot trial of combination therapy with interferon beta-1a and mycophenolate mofetil in early relapsing-remitting multiple sclerosis (TIME MS).Pharmacokinetics and pharmacodynamics of mycophenolic acid and their relation to response to therapy of childhood-onset systemic lupus erythematosusThe emergence of mycophenolate mofetilin dermatology: from its roots in the world of organ transplantation to its versatile role in the dermatology treatment room.Treatment of Cutaneous Lupus Erythematosus: Review and Assessment of Treatment Benefits Based on Oxford Centre for Evidence-based Medicine Criteria.Update on the use of topical calcineurin inhibitors in cutaneous lupus erythematosus.Mycophenolate in dermatology.Mycophenolate mofetil and systemic lupus erythematosus: an overview.Mycophenolate mofetil and skin diseases.Cutaneous lupus erythematosus: a personal approach to management.Mycophenylate mofetil: what role in the treatment of lupus?Emerging drug therapies for systemic lupus erythematosus.Azathioprine: a guide for the management of dermatology patients.Lupus erythematosus: considerations about clinical, cutaneous and therapeutic aspects.Update on emerging drug therapies for systemic lupus erythematosus.Management of systemic lupus erythematosus in Chinese patients.Practical guidelines for the use of steroid-sparing agents in the treatment of chronic pruritus.Systemic use of non-biologics in orofacial diseases: 2. Purine synthesis inhibitors.Mycophenolate mofetil in the treatment of systemic lupus erythematosus.Mycophenolate sodium for subacute cutaneous lupus erythematosus resistant to standard therapy.Coexisting subacute and systemic lupus erythematosus after terbinafine administration: successful treatment with mycophenolate mofetil.Mycophenolate mofetil: a novel immunosuppressant in the treatment of dystrophic epidermolysis bullosa, a randomized controlled trial.[Systemic treatment of cutaneous lupus erythematosus].S2k guideline for treatment of cutaneous lupus erythematosus - guided by the European Dermatology Forum (EDF) in cooperation with the European Academy of Dermatology and Venereology (EADV).
P2860
Q26741266-834AB942-1232-461A-A8FB-88334B92AC19Q31121574-AF4C022E-D0C0-4AAF-AE91-910C2A8A7AF5Q33377162-8929B658-F9FD-42BD-A453-53F8BBA788F1Q34409297-C53F1301-D50F-42A8-B7CB-0F73B98584EEQ34409308-6F528853-D989-465A-8FE4-BE542E3F0704Q34494943-4617621A-2702-4B8C-A768-6B75BDC6D54FQ34536203-275894AD-A89D-4D3E-96CB-BEAE3F614AFCQ34548422-C03A9D8A-40F2-47FC-9984-670DDF4C5691Q34605279-75A9B34D-11FB-4521-A837-D5DF1A06210FQ35601973-066DA898-C895-4D63-8228-E3C1C8DB4F9EQ36085845-963D870E-EED9-47C5-8D3F-1771EA67F770Q36085882-85E5BB4D-83C5-4521-9552-A98053828A86Q36365400-7422B326-4977-4493-ACA8-75D5E1A7BB1DQ36458168-4DCDD9CC-3F29-49BD-B397-9E8B05A70DDEQ36634248-54E5093F-B628-4D78-A12B-D3981ACC1433Q36986021-FC22DBFF-BF07-4146-81C4-9FD4186BACB3Q37609869-42F3A51D-9F59-4D37-B811-6972AC5787AAQ37690745-F39999C2-EBF3-439D-B60A-5A727D1D608AQ37754815-B86C096F-A644-4767-B4F8-3B210BE58060Q38095599-F077D004-56CD-41ED-8611-237148BFD4EEQ38120321-BB6F9891-1DE7-4749-B98B-6FCFF8132A4BQ38327763-FF496207-148F-45F9-B262-3AF92FB7E8D4Q42616372-B3D3242F-A017-4D3C-A72C-EBAE6E34A437Q44153828-AD3E6C5C-9BA8-4CA6-AFEB-88FE322ABEEFQ46540016-D7F47D48-66E1-4889-9DDE-9FF763570B5BQ46801766-3ED1CB16-270F-4418-910F-8511E7EE701DQ52836583-D49782CC-3DF1-4AC4-AB5B-EF7B9923044C
P2860
Successful treatment of subacute cutaneous lupus erythematosus with mycophenolate mofetil.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh-hant
name
Successful treatment of subacu ...... us with mycophenolate mofetil.
@en
Successful treatment of subacu ...... us with mycophenolate mofetil.
@nl
type
label
Successful treatment of subacu ...... us with mycophenolate mofetil.
@en
Successful treatment of subacu ...... us with mycophenolate mofetil.
@nl
prefLabel
Successful treatment of subacu ...... us with mycophenolate mofetil.
@en
Successful treatment of subacu ...... us with mycophenolate mofetil.
@nl
P2093
P2860
P1476
Successful treatment of subacu ...... us with mycophenolate mofetil.
@en
P2093
P2860
P304
P356
10.1046/J.1365-2133.2002.04875.X
P407
P577
2002-07-01T00:00:00Z